MIT Corporation life member and biotech pioneer Henri Termeer dies at 71
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Study at MIT Medical finds most parents are capable of performing the test.
By measuring this emerging vital sign, CSAIL system could help monitor and diagnose health issues like cognitive decline and cardiac disease.
In more than 20 years working on wireless sensors and radio frequency identification (RFID), Richard Fletcher has produced several startups and over a dozen patents.
MIT Violence Prevention and Response and Title IX Office recognize students, faculty, and staff with 2017 Change Makers Awards.
New research on ready-to-use therapeutic food seeks drastic reduction in fatalities from severe acute malnutrition in India.
Proposals are invited for basic and translational environmental health sciences research.
Koch Institute director advocates support for biomedical research in testimony before the House Committee on Oversight and Government Reform.
Specialized droplets interact with bacteria and can be analyzed using a smartphone.
Beckman Foundation grant helps secure cryo-electron microscopy at MIT.nano facility.
Rubbery, multifunctional fibers could be used to study spinal cord neurons and potentially restore function.
New research shows large spillover from the lab to commercial activity.
Countries hit hardest by automaker’s emissions scandal include Germany, Poland, France, and Czech Republic.
Measuring the parasite’s heme levels could help scientists develop better antimalarial drugs.
Eight student teams pitched novel inventions at MIT Sloan Healthcare Innovations Prize competition.